Wordt geladen...
A high-affinity RBD-targeting nanobody improves fusion partner’s potency against SARS-CoV-2
A key step to the SARS-CoV-2 infection is the attachment of its Spike receptor-binding domain (S RBD) to the host receptor ACE2. Considerable research has been devoted to the development of neutralizing antibodies, including llama-derived single-chain nanobodies, to target the receptor-binding motif...
Bewaard in:
| Gepubliceerd in: | PLoS Pathog |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Public Library of Science
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7959386/ https://ncbi.nlm.nih.gov/pubmed/33657135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.ppat.1009328 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|